In the imiquimod-induced, IL (interleukin)-23-dependent, psoriasis-like skin of mice, SCN10A+ nociceptors interact with DDCs, regulate the IL-23/IL-17 pathway, and control cutaneous immune responses [28]. Here, IL17A is linked to psoriasis.